Maxim Biomedical Inc. Receives EUA for New ClearDetect™ COVID-19 Antigen Home Test

/PRNewswire/ -- On January 19, 2022, Maxim Biomedical (MaximBio) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for...

Related Keywords

Jonathan Maa ,Department Of Health ,Human Services ,National Institutes Of Health ,Drug Administration Emergency Use Authorization ,National Institute Of Biomedical Imaging ,Maxim Biomedical Inc ,Home Test ,Positive Agreement ,Negative Agreement ,Maxim Biomedical ,National Institute ,Biomedical Imaging ,National Institutes ,Antigen Diagnostic Test ,Drug Administration ,Emergency Use ,Nc ,